---
title: "Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 | ALGS Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286205055.md"
description: "Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 | ALGS Stock News"
datetime: "2026-05-12T22:05:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286205055.md)
  - [en](https://longbridge.com/en/news/286205055.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286205055.md)
---

# Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 | ALGS Stock News

Aligos Therapeutics Announces Ten Abstracts Accepted for Presentation at the EASL Congress 2026 | ALGS Stock News

### Related Stocks

- [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [IHE.US](https://longbridge.com/en/quote/IHE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Aligos Q2 FY26 net loss narrows 91% to $1.5 million](https://longbridge.com/en/news/295103944.md)
- [Medicare is about to change a drug program that held down the cost of premiums. Here's what to know.](https://longbridge.com/en/news/294391519.md)
- [Aligos Therapeutics Presents Positive Data at the EASL Congress 2026 | ALGS Stock News](https://longbridge.com/en/news/287726278.md)
- [HEDGE FLOW-Hedge fund bets on rising US healthcare stocks near 5-year high, Goldman says](https://longbridge.com/en/news/293938581.md)
- [Aligos completes enrollment in Phase 2 B-SUPREME trial for chronic hepatitis B drug pevifoscorvir sodium](https://longbridge.com/en/news/292485727.md)